Nadine Kutsch

1.4k total citations
34 papers, 461 citations indexed

About

Nadine Kutsch is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Nadine Kutsch has authored 34 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 15 papers in Pathology and Forensic Medicine and 11 papers in Immunology. Recurrent topics in Nadine Kutsch's work include Chronic Lymphocytic Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (15 papers) and CAR-T cell therapy research (10 papers). Nadine Kutsch is often cited by papers focused on Chronic Lymphocytic Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (15 papers) and CAR-T cell therapy research (10 papers). Nadine Kutsch collaborates with scholars based in Germany, United States and United Kingdom. Nadine Kutsch's co-authors include Michael Hallek, Christian P. Pallasch, Clemens‐Martin Wendtner, Lukas P. Frenzel, Janine Schwamb, Alexandra Schulz, Daniela Eggle, Adam Drake, Barbara Eichhorst and Lukas C. Heukamp and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Blood.

In The Last Decade

Nadine Kutsch

30 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadine Kutsch Germany	9	167	166	145	127	111	34	461
Jani Huuhtanen Finland	11	335 2.0×	250 1.5×	90 0.6×	268 2.1×	57 0.5×	25	595
Hodjatallah Rabbani Iran	16	249 1.5×	233 1.4×	158 1.1×	107 0.8×	78 0.7×	31	517
Nicholas Shinners United States	12	407 2.4×	214 1.3×	106 0.7×	313 2.5×	136 1.2×	19	743
Ursula R. Sorg Germany	13	186 1.1×	254 1.5×	73 0.5×	177 1.4×	47 0.4×	26	580
Selda Samakoglu United States	12	165 1.0×	188 1.1×	165 1.1×	353 2.8×	258 2.3×	20	635
Cassandra Love United States	11	163 1.0×	342 2.1×	127 0.9×	250 2.0×	179 1.6×	23	684
Kristina McConnell United States	6	123 0.7×	234 1.4×	185 1.3×	138 1.1×	85 0.8×	6	459
Rachael Siegel United States	8	299 1.8×	475 2.9×	207 1.4×	99 0.8×	123 1.1×	10	827
Sophie Péron France	13	520 3.1×	200 1.2×	72 0.5×	71 0.6×	67 0.6×	21	670

Countries citing papers authored by Nadine Kutsch

Since Specialization

Citations

This map shows the geographic impact of Nadine Kutsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadine Kutsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadine Kutsch more than expected).

Fields of papers citing papers by Nadine Kutsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadine Kutsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadine Kutsch. The network helps show where Nadine Kutsch may publish in the future.

Co-authorship network of co-authors of Nadine Kutsch

This figure shows the co-authorship network connecting the top 25 collaborators of Nadine Kutsch. A scholar is included among the top collaborators of Nadine Kutsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadine Kutsch. Nadine Kutsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goede, Valentin, Kirsten Fischer, Sandra Robrecht, et al.. (2025). Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia. Blood Advances. 9(10). 2431–2435. 1 indexed citations

Kutsch, Nadine, Philipp Gödel, Conrad‐Amadeus Voltin, et al.. (2024). Long‐term remission in a patient with relapsed Richter's transformation treated with CD19‐directed chimeric antigen‐receptor T‐cells after allogeneic stem cell transplantation. European Journal Of Haematology. 112(6). 984–987. 1 indexed citations

Mackensen, Andréas, Winfried Alsdorf, Daniel Heudobler, et al.. (2024). 611O Updated results from BNT211-01 (NCT04503278), an ongoing, first-in-human, phase I study evaluating safety and efficacy of CLDN6 CAR T cells and a CLDN6-encoding mRNA vaccine in patients with relapsed/refractory CLDN6+ solid tumors. Annals of Oncology. 35. S489–S490. 7 indexed citations

Tresckow, Julia von, Sandra Robrecht, Anna‐Maria Fink, et al.. (2024). CLL-465 Second Primary Malignancies (SPMs) in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With the Combination of a Targeted Agent With an Antibody in 4 Phase 2 Trials of the German CLL Study Group (GCLLSG). Clinical Lymphoma Myeloma & Leukemia. 24. S354–S355.

Mackensen, Andréas, Winfried Alsdorf, Christian Koenecke, et al.. (2023). LBA35 BNT211-01: Interim results from a repeat dose escalation study of CLDN6 CAR-T cells manufactured with an automated process ± a CLDN6-encoding CAR-T cell-amplifying RNA Vaccine (CARVac). Annals of Oncology. 34. S1274–S1275. 1 indexed citations

Kutsch, Nadine, Rudy Ligtvoet, Sandra Robrecht, et al.. (2023). Outcomes and Treatment Sequences of Therapies with BCL2- and BTK Inhibitors in Chronic Lymphocytic Leukemia (CLL): An Analysis of Patient Data within the German CLL Study Group (GCLLSG) Registry. Blood. 142(Supplement 1). 4644–4644. 3 indexed citations

Kaddu‐Mulindwa, Dominic, Philipp Gödel, Nadine Kutsch, et al.. (2022). Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 22(7). e498–e506. 1 indexed citations

Heger, Jan‐Michel, Philipp Gödel, Hyatt Balke‐Want, et al.. (2022). Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-Sequencing. Blood. 140(Supplement 1). 3537–3538. 1 indexed citations

Kutsch, Nadine, Philipp Gödel, Udo Holtick, et al.. (2022). A Phase I Dose Finding Trial of MB-CART20.1 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood. 140(Supplement 1). 12980–12981. 2 indexed citations

10.

Kutsch, Nadine, Philipp Gödel, Conrad‐Amadeus Voltin, et al.. (2022). Sustained Remission of Relapsed Diffuse Large B-cell Lymphoma After Safe Administration of CD19-directed CAR T-cells in a Patient With Chronic Intestinal and Pulmonal GvHD. HemaSphere. 6(7). e735–e735. 1 indexed citations

11.

Al‐Sawaf, Othman, Brittany Gentile, Jacob Devine, et al.. (2021). Health‐related quality of life with fixed‐duration venetoclax‐obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial. American Journal of Hematology. 96(9). 1112–1119. 8 indexed citations

12.

Al‐Sawaf, Othman, Alexandra Bazeos, Sandra Robrecht, et al.. (2019). Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL). American Journal of Hematology. 94(9). 1002–1006. 5 indexed citations

13.

Goede, Valentin, Jasmin Bahlo, Nadine Kutsch, et al.. (2016). Evaluation of the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) in Elderly Patients with Comorbidities: Analysis of the CLL11 Study Population. Blood. 128(22). 4401–4401. 7 indexed citations

14.

Bahlo, Jasmin, Nadine Kutsch, Michael Bergmann, et al.. (2015). THE INTERNATIONAL PROGNOSTIC INDEX FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI)-AN INTERNATIONAL META-ANALYSIS. Haematologica. 100. 313–314. 6 indexed citations

15.

Kutsch, Nadine, Jasmin Bahlo, John C. Byrd, et al.. (2015). The international Prognostic Index for patients with CLL (CLL-IPI): An international meta-analysis.. Journal of Clinical Oncology. 33(15_suppl). 7002–7002. 14 indexed citations

16.

Kutsch, Nadine, Reinhard Marks, Richard Ratei, Thomas Held, & Martin Schmidt‐Hieber. (2015). Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms. Biomarker Insights. 10s3(Suppl 3). BMI.S22434–BMI.S22434. 3 indexed citations

17.

Pallasch, Christian P., Ilya Leskov, Christian Braun, et al.. (2014). Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy. Cell. 156(3). 590–602. 130 indexed citations

18.

Kutsch, Nadine, Michael Hallek, & Barbara Eichhorst. (2014). Emerging therapies for refractory chronic lymphocytic leukemia. Leukemia & lymphoma. 56(2). 285–292. 3 indexed citations

19.

Pallasch, Christian P., Michaela Patz, Yoon Jung Park, et al.. (2009). miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood. 114(15). 3255–3264. 118 indexed citations

20.

Pallasch, Christian P., Alexandra Schulz, Nadine Kutsch, et al.. (2008). Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease. Blood. 112(10). 4213–4219. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact